Getting around muscle aging
Researchers have discovered that it is possible to modulate the function of immune cells to recover muscle regeneration capacity in aging mice. …
Toxic protein linked to muscular dystrophy may cause rare facial malformation
A toxic protein made by the body may cause two different rare genetic disorders, facioscapulohumeral muscular dystrophy (FSHD) and a rare facial malformation called arhinia (absent nose). …
Dry eye disease alters how the eye’s cornea heals itself after injury
The identification of proteins made by stem cells that regenerate the cornea may be new targets for treating and preventing corneal injuries in dry eye disease. …
Infection of visceral fat cells may contribute to severe COVID-19
New study suggests visceral fat – a risk factor for cardiovascular disease and diabetes – contributes more to severe COVID-19 than subcutaneous fat. …
Senescent cells help to heal damaged tissues
New research reveals that not all senescent cells are harmful “zombies” that should be wiped out to prevent age-related disease. …
Stem cell-based therapy shows promise in treating high-risk type 1 diabetes
An investigative stem cell-based therapy designed to act as a pancreas replacement has the potential to provide blood sugar control in patients with high-risk type 1 diabetes. …
Stem-cell models reveal glaucoma’s secrets
Stem cell models of the retina and optical nerve have been used to identify previously unknown genetic markers of glaucoma. …
Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant
Newly diagnosed multiple myeloma patients treated with a three-drug combination lived longer without their disease worsening if they received an autologous stem cell transplant soon after drug therapy. …
Hunting for the immune cells that predispose people to severe COVID-19
A subtype of macrophages in the lungs determine how likely COVID-19 patients are to develop severe disease. …
Stem cell therapy protects against the side effects of cancer immunotherapy
Mesenchymal stem cell therapy suppresses the onset of type 1 diabetes induced by cancer immunotherapy. …
End of content
End of content
